Brief: Incannex Granted FDA Fast Track Designation For IHL-42X In Obstructive Sleep Apnea
03/12/2025 13:13
Dec 3 (Reuters) - Incannex Healthcare Inc IXHL.O: INCANNEX GRANTED FDA FAST TRACK DESIGNATION FOR IHL-42X IN OBSTRUCTIVE SLEEP APNEA (OSA) Source text: ID:nGNXb9FhXR Further company coverage: IXHL.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Incannex Healthcare
See all newsIncannex Healthcare Inc reports results for the quarter ended June 30 - Earnings Summary
Incannex Healthcare Inc expected to post a loss of 75 cents a share - Earnings Preview
Brief: Incannex Receives Additional A$5.1 Million Research And Development Tax Incentive Refund
Brief: Incannex Healthcare Commences DReAMzz Clinical Study Of IHL-42X For Obstructive Sleep Apnea
Brief: Incannex Reactivates Share Repurchase Program, Underscoring Confidence In Valuation And Strategic Position